Description

Lenalidomide 25 mg

Lenalidomide 25 mg is an immunomodulatory medication primarily used in the treatment of certain blood cancers and bone marrow disorders. It is a derivative of thalidomide and works by affecting the immune system, inhibiting the growth of abnormal cells, and reducing the formation of new blood vessels that support tumor growth.

Therapeutic Uses

Lenalidomide 25 mg is commonly prescribed for:

• Multiple myeloma, often in combination with other anticancer medications.
• Myelodysplastic syndromes (MDS) associated with specific chromosomal abnormalities.
• Mantle cell lymphoma.
• Follicular lymphoma and certain other hematologic malignancies, depending on regional approvals and treatment guidelines.

Mechanism of Action

Lenalidomide exerts its therapeutic effects through multiple mechanisms:

• Enhancing immune system activity against abnormal cells.
• Inhibiting the proliferation of malignant cells.
• Promoting programmed cell death (apoptosis).
• Reducing angiogenesis, the process by which tumors develop new blood vessels.

Dosage and Administration

The 25 mg strength is typically administered orally once daily according to a treatment cycle prescribed by a healthcare professional. Dosage adjustments may be required based on kidney function, treatment response, and adverse effects.

Common Side Effects

Patients receiving Lenalidomide 25 mg may experience:

• Fatigue
• Neutropenia (low white blood cell count)
• Thrombocytopenia (low platelet count)
• Anemia
• Diarrhea or constipation
• Rash
• Muscle cramps

Important Safety Information

Lenalidomide can cause serious adverse effects, including severe birth defects if taken during pregnancy. Effective contraception and adherence to risk-management programs are essential for patients of reproductive potential. Regular monitoring of blood counts and overall health status is recommended throughout treatment.

Storage

Store Lenalidomide 25 mg capsules at room temperature, protected from excessive heat and moisture, and keep them out of reach of children.

Disclaimer

Lenalidomide 25 mg should only be used under the supervision of a qualified healthcare professional. Treatment decisions should be based on individual patient characteristics and current clinical guidelines.